Sep. 5 at 4:04 PM
$CCCC For entertainment purposes only - I am thinking
$CCCC going over
$3 very soon. Why?
Recent developments the past couple days:
1. Upgraded stock price to
$8;
2. Positive development with BIogen collaboration
3. Biogen Collaboration Milestone As FDA Accepts IND For BIIB142, An IRAK4 Degrader Targeting Autoimmune Diseases
4. Upcoming ORAL (not poster, Oral more impactful than poster) presentation titled "Updated Results of a Phase 1 First-in-Human Study of Cemsidomide (CFT7455), a Novel MonoDAC(R) Degrader, with Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma."
Less recent:
5. Preclinical Milestone Achieved Under the Collaboration With Merck KGaA, Darmstadt, Germany, Which Is Focused on Two Projects Within the KRAS Family
6. And still with an astonishing ~
$200,000,000 cash!
Add in my baseless, wild speculation of a positive Chinese Surprise from CCCC partner Betta and I am thinking well over
$3 is possible. Good luck.
